Inogen | INGN - Cost Of Sales


Inogen reported $39.59M in Cost of Sales for its fiscal quarter ending in September of 2024.





Cost Of Sales Change Date
Abbott USD 4.92B 535M Dec/2025
Accuray USD 116.17M 14.63M Dec/2024
AngioDynamics USD 37.29M 786K Sep/2025
Artivion USD 42.85M 3.86M Dec/2025
AtriCure USD 35.16M 2.23M Dec/2025
Baxter International USD 2.4B 512M Dec/2025
Becton, Dickinson and Co. USD 2.84B 2.35B Dec/2025
Boston Scientific USD 1.84B 82M Dec/2025
Chart Industries USD 775M 7.5M Sep/2025
Cooper Companies USD 376.8M 87.4M Dec/2025
Dexcom USD 466.9M 11M Dec/2025
Edwards Lifesciences USD 343M 2.2M Dec/2025
Globus Medical USD 290.47M 8.09M Dec/2025
Inogen USD 39.59M 1.27M Sep/2024
Insulet USD 215.2M 19M Dec/2025
Masimo USD 165.2M 24.3M Dec/2025
Medtronic USD 3.61B 83M Dec/2025
Orthofix International USD 66.63M 6.4M Dec/2025
Philips EUR 2.81B 417M Dec/2025
ResMed USD 555.85M 29.13M Dec/2025
Steris USD 840.7M 26.3M Dec/2025
Stryker USD 2.69B 373M Dec/2025
Tandem Diabetes Care USD 122.92M 7.96M Dec/2025
Teleflex USD 261.54M 199.84M Dec/2025
X T L Biopharmaceuticals USD 332K 216K Dec/2024
Zimmer Biomet Holdings USD 970.1M 234.3M Dec/2025